TAK-079
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for TAK-079, covering 2017-05-03 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) [Phase 1]